Navigation Biologie des maladies cardiovasculaires (BMC) - UMR 1034 par Titre
Voici les éléments 39-58 de 331
-
Validation d’une échelle de mesure de l’adhésion médicamenteuse cardiovasculaire utilisable en contexte hospitalier
(Annales Pharmaceutiques Françaises, 2020-02-11)Article de revueLibre accès -
Experts' recommendations for the management of adult patients with cardiogenic shock
(Annals of intensive care. vol. 5, pp. 52, 2015-12)Article de revueLibre accès -
Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and The Risk of Under and Overdosing.
(Crit Care Med. vol. 45, n° 5, pp. e–470–e478, 2017-02)Article de revueLibre accès -
Impact of dexamethasone use to prevent from severe COVID-19-induced acute kidney injury.
(Critical Care. vol. 25, n° 1, pp. 249, 2021-07-16)Article de revueLibre accès -
Mutations of the integrin αIIb/β3 intracytoplasmic salt bridge cause macrothrombocytopenia and enlarged platelet α-granules.
(Am J Hematol. vol. 93, n° 2, pp. 195–204, 2018-02)Article de revueAccès réservé -
Anti-αIIb β3 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations
(British Journal of Haematology. vol. 181, n° 2, pp. 173–182, 2018-04)Article de revue -
Evaluation of the potential utility of the total thrombus-formation analysis system in comparison to the platelet function analyser in subjects with primary haemostatic defects.
(British Journal of Haematology. vol. 191, n° 1, pp. e7-e10, 2020-10-01)Article de revue -
Characterizing Vascular Dysfunction in Genetically Modified Mice through the Hyperoxia Model
(International Journal of Molecular Sciences. vol. 20, n° 9, pp. 2178, 2019-05)Article de revueLibre accès -
First description of an IgM monoclonal antibody causing αIIb β3 integrin activation and acquired Glanzmann thrombasthenia associated with macrothrombocytopenia
(Journal of Thrombosis and Haemostasis. vol. 17, n° 5, pp. 795–802, 2019-03)Article de revueLibre accès -
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
(British Journal of Haematology. vol. 188, n° 6, pp. 935–944, 2020)Article de revue -
Function, Dysfunction, and Normality in Biological Sciences
(Biol Theory. vol. 10, 2018-01)Article de revue -
Diagnosis and management of heparin-induced thrombocytopenia
(Anaesthesia Critical Care & Pain Medicine. vol. 39, n° 2, pp. 291–310, 2020-04-20)Article de revueLibre accès -
Assessment of light transmission aggregometry on the routine coagulation analyzer Sysmex CS-2500 using CE-marked agonists from Hyphen Biomed
(Platelets. vol. 30, n° 4, pp. 540–542, 2019-05)Article de revue -
Comparison of Two Thrombin Generation Methods, CAT and ST-Genesia, in Liver Transplant Patients
(Thrombosis and Haemostasis. vol. 119, n° 6, pp. 899–905, 2019-06)Article de revue -
Left ventricular unloading did not decrease mortality in cardiogenic shocks patients supported with VA-ECMO: A propensity score matching study.
(Anaesthesia Critical Care & Pain Medicine. vol. 41, n° 2, pp. 101042, 2022-02-17)Article de revue -
ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia
(Platelets. vol. 29(1), n° 98-101, 2018-01)Article de revue -
Fzd7 (Frizzled-7) Expressed by Endothelial Cells Controls Blood Vessel Formation Through Wnt/β-Catenin Canonical Signaling.
(Arteriosclerosis, Thrombosis, and Vascular Biology. vol. 36, n° 12, pp. 2369–2380, 2016-12)Article de revueLibre accès -
Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019
(Clinical Kidney Journal. pp. sfaa099, 2020-08-19)Article de revueLibre accès -
Observations on the perfusion recovery of regenerative angiogenesis in an ischemic limb model under hyperoxia
(Physiological Reports. vol. 6, n° 12, pp. e13736, 2018-05)Article de revueLibre accès -
Decrease of thoracopulmonary compliance with pressure assist controlled ventilation in ARDS patients under ECMO and transported to a referral centre.
(Intensive Care Medicine. vol. 43(1), pp. 148–149, 2016-11)Article de revue